The PE Ratio as of December 2024 (TTM) for Seer, Inc. (SEER) is -1.70

According to Seer, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.70. This represents a change of 16.93% compared to the average of -1.45 of the last 4 quarters.

Seer, Inc. (SEER) Historical PE Ratio (quarterly & annually)

How has SEER PE Ratio performed in the past?

The mean historical PE Ratio of Seer, Inc. over the last ten years is -90.31. The current -1.70 PE Ratio has changed 88.23% with respect to the historical average. Over the past ten years (40 quarters), SEER's PE Ratio was at its highest in in the June 2024 quarter at -1.19. The PE Ratio was at its lowest in in the September 2020 quarter at -100.23.

Seer, Inc. (SEER) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Seer, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Seer, Inc. (SEER) Average PE Ratio

How has SEER PE Ratio performed in the past?

The current PE Ratio of Seer, Inc. (SEER) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Seer, Inc. (SEER) PE Ratio vs. Peers

How is SEER’s PE Ratio compared to its peers?

Seer, Inc.’s PE Ratio is greater than ORIC Pharmaceuticals, Inc. (-4.82), greater than Anebulo Pharmaceuticals, Inc. (-5.30), greater than Cullinan Oncology, Inc. (-4.99), greater than C4 Therapeutics, Inc. (-2.55), greater than Molecular Partners AG (-2.46), greater than Mineralys Therapeutics, Inc. (-4.16), less than AN2 Therapeutics, Inc. (-0.67), greater than Pharvaris N.V. (-7.33), less than PepGen Inc. (-1.51), greater than Foghorn Therapeutics Inc. (-3.45), less than Shattuck Labs, Inc. (-0.76), greater than Monte Rosa Therapeutics, Inc. (-4.84), greater than Kymera Therapeutics, Inc. (-18.55), greater than Nurix Therapeutics, Inc. (-8.05), greater than Quantum-Si incorporated (-2.06), less than HCW Biologics Inc. (-0.40), less than MediciNova, Inc. (-0.04), less than Nkarta, Inc. (-1.56), less than Lyell Immunopharma, Inc. (-0.77), less than Generation Bio Co. (-0.49), less than Sana Biotechnology, Inc. (-1.35),

Build a custom stock screener for Seer, Inc. (SEER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seer, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Seer, Inc. (SEER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Seer, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.